688310 Maider Medical Industry Equipment Co. Ltd.
- 25.26
- +1.59+6.72%
Maider Medical Industry Equipment Co. Ltd. News
Medtech Healthcare (688310.SH) announced first-quarter results, net profit of 10.513,200 yuan, down 21.61% year-on-year
Zhitong Finance App News, Medtech Healthcare (688310.SH) disclosed its report for the first quarter of 2024. The company achieved revenue of 74.229 million yuan during the reporting period, an increase of 2.08% over the previous year. Net profit attributable to shareholders of listed companies was 10.513,200 yuan, a year-on-year decrease of 21.61%. Net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 8.5241 million yuan, a year-on-year decrease of 25.12%. Basic earnings per share were 0.09 yuan/share.
Should Weakness in Maider Medical Industry Equipment Co. Ltd.'s (SHSE:688310) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
Maider Medical Industry Equipment (SHSE:688310) has had a rough three months with its share price down 15%. However, the company's fundamentals look pretty decent, and long-term financials are usual
Some Investors May Be Worried About Maider Medical Industry Equipment's (SHSE:688310) Returns On Capital
If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Firstly, we'll want to see a proven return on capital employed (ROCE) that is increasing, and se
Medtech Healthcare (688310.SH) performance report: 2023 net profit of 103 million yuan increased 54.24% year on year
On February 23, Ge Longhui (688310.SH) announced the 2023 Annual Results Report. In 2023, the company achieved operating revenue of 481 million yuan, an increase of 25.41% compared with the same period last year; achieved net profit attributable to owners of the parent company of 103 million yuan, an increase of 54.24% over the same period last year; realized net profit attributable to owners of the parent company after deducting non-recurring profit and loss of 89.1013 million yuan, an increase of 54.68% compared with the same period last year.
Maider Medical Industry Equipment Co. Ltd.'s (SHSE:688310) Most Bullish Insider Is Chairman of Management Board Junhua Li, and Their Holdings Value Went up by 20% Last Week
Key Insights Insiders appear to have a vested interest in Maider Medical Industry Equipment's growth, as seen by their sizeable ownership 62% of the business is held by the top 2 shareholders 19%
Express News | Maide Healthcare: Pre-profit of about 103 million yuan in 2023, a year-on-year increase of about 54.24%
Medtech Healthcare (688310.SH): Net profit expected to increase by about 54.24% in 2023
On January 26, Ge Longhui Medical (688310.SH) announced its 2023 annual results forecast. According to preliminary estimates by the finance department, it is expected to achieve operating income of about 48,0926,800 yuan in 2023. Compared with the same period last year (statutory disclosure data), it will increase by about 97.437 million yuan, an increase of about 25.41% over the previous year. The net profit attributable to the owner of the parent company is expected to be around RMB 103.3845 million in 2023. Compared with the same period last year (statutory disclosure data), it will increase by about RMB 36.3579 million, an increase of 54.2 million yuan over the previous year
The Market Doesn't Like What It Sees From Maider Medical Industry Equipment Co. Ltd.'s (SHSE:688310) Earnings Yet As Shares Tumble 26%
The Maider Medical Industry Equipment Co. Ltd. (SHSE:688310) share price has fared very poorly over the last month, falling by a substantial 26%. Still, a bad month hasn't completely ruined the pas
If EPS Growth Is Important To You, Maider Medical Industry Equipment (SHSE:688310) Presents An Opportunity
The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even companies that have no revenue, no profit, and a record of falling short, can manage
(Maide Healthcare 688310): Significant increase in gross margin, contact lens business is expected to start a second growth curve
Event: The company released its three-quarter report for 2023, achieving revenue of 330 million yuan (+67.1%) in Q1-Q3 in 2023; net profit of 71.77 million (+272.1%); net profit of 63.67 million (+272.1%); deduction of non-return net profit of 63
Maide Medical (688310.SH): The company's products, medical consumables and intelligent equipment, are non-standard customized equipment
On October 31, Gelonghui Healthcare (688310.SH) stated on the investor interactive platform that the company's products, medical consumables, and intelligent equipment are non-standard customized equipment. The company will require customers to pay a certain percentage of prepayment according to the credit status of different customers, the difficulty of different categories of products, and the company's marketing strategies.
Maide Healthcare (688310.SH): The company's contact lens business is still in the product registration stage
Glonghui, October 31: Some investors asked Maide Healthcare (688310.SH) on the investor interactive platform. “Has the company submitted a registration application for contact lenses? When is it expected that it will be produced and shipped?” The company said that the company's contact lens business is still in the product registration stage, and currently it has submitted three types of medical device registration applications.
Maide Healthcare (688310.SH): The average order completion cycle of the company is 6 months
On October 31, Glonghui, on the investor interactive platform, some investors asked Maide Healthcare (688310.SH), “When the company's production capacity utilization rate is high, will the pace of production expansion be expanded according to demand, and announcements will be made? “How long does it usually take for equipment from order placement to delivery” The company said that the company will strictly disclose information in accordance with relevant regulations, and the average order completion cycle for the company is 6 months.
Maide Healthcare (688310): Performance exceeds expectations, and contact lenses are expected to bring new growth points
Event: The company released its three-quarter report for 2023. 2023Q3 revenue was 130 million yuan (+105.9%), net profit was 0.3 billion yuan (+266%), and cumulative revenue for the first three quarters was 330 million yuan (+67.1%), resulting in total revenue of 330 million yuan (+67.1%)
Returns On Capital At Maider Medical Industry Equipment (SHSE:688310) Have Stalled
If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Typically, we'll want to notice a trend of growing return on capital employed (ROCE) and alongsi
Medtech Healthcare (688310.SH) released its results for the first three quarters, with net profit of 71.77 million yuan, an increase of 272.08% over the previous year
Maide Healthcare (688310.SH) disclosed the report for the third quarter of 2023. The company achieved revenue of 3 in the first three quarters...
Adopted shares (301122.SZ): There is currently no business cooperation with Maide Medical
GLONGHUI, Oct. 23 丨 Some investors asked Adopted Shares (301122.SZ) on the investor interactive platform, “Does your company purchase automation equipment from MedCare?” The company replied that the company has not yet developed a business cooperation with Maide Medical.
Medtech Healthcare (688310.SH): Currently, the capacity utilization rate is high
GLONGHUI, Oct. 23 | Maide Healthcare (688310.SH) said on the investor interactive platform that the company's current capacity utilization rate is high. According to the strategic development plan, the company plans to use some of the overraised capital to invest in the construction of new projects.
MedCare (688310.SH): Novo Nordisk and Eli Lilly are not the company's customers
Medtech Healthcare (688310.SH) said on the investor interactive platform that the company's single-use injection pen equipment can produce injection pens for various application scenarios such as insulin injections, vaccines, and biopharmaceuticals (SIMEI). Novo Nordisk and Lilly are not customers of the company, and the company will actively develop customers related to injection pens.
Medtech Healthcare (688310.SH): Currently, the company's contact lens business is still in the product registration stage
Glonghui, Oct. 17: On the investor interactive platform, Maide Healthcare (688310.SH) said that the company's self-built production line is already capable of producing hydrogel contact lens samples (transparent lenses and tinted films). The cycle covers daily, monthly, and seasonal polishing. Currently, the company's contact lens business is still in the product registration stage.
Analysis
Price Target
No Data
